Statins found to prevent chronic inflammation-related cancers by inhibiting interleukin-33

FHS
June 3, 2024
9:45 am

The effects of statins via inhibition of interleukin 33 (IL-33).

PhRMA and BIO say Biden’s march-in proposal creates uncertainty in industry

PhRMA president Stephen Ubl argued Thursday that the Biden administration’s new proposal on the use of march-in rights has “planted the seeds of uncertainty” around

December 15, 2023

Rice University leads development of innovative bioelectronic implant for obesity and diabetes

Rice University is part of a multiuniversity research team that has secured an award of up to $34.9 million from the Advanced Research Projects Agency

October 3, 2024

Ubiquigent collaborates with Imperial College London on DUB probe discovery to facilitate preclinical and clinical target engagement studies

Ubiquigent Limited (Ubiquigent), a drug discovery and development company harnessing novel deubiquitinase (DUB) modulators as new therapeutics for areas of high unmet medical need, today

October 4, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.